Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device Reports To FDA Rose 77% In 2006

This article was originally published in The Gray Sheet

Executive Summary

The number of adverse events reported to FDA under the Medical Device Reporting (MDR) program rose last year to an all-time high, and agency staffers predict the trend will continue through 2007

You may also be interested in...



In Search Of Missing Adverse Events, U.K. Looks To Expand Online Reporting

The United Kingdom's device regulators are trying to reverse a trend of under-reporting of medical device adverse events by health care practitioners

In Search Of Missing Adverse Events, U.K. Looks To Expand Online Reporting

The United Kingdom's device regulators are trying to reverse a trend of under-reporting of medical device adverse events by health care practitioners

CDRH Considers Internet Forum To Aid Device Safety Surveillance

FDA's device center is assessing whether an online forum for physicians can help with its postmarket surveillance challenges

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel